Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.54 |
| ▸ | ACHE | P22303 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | ACP3 | P15309 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.39 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.39 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.38 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.38 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.38 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13993318 | 0.88 | ESR1 (0.59) | ESR1ACHETSHRGAAACP3 | |
| Glycerin SCHEMBL15914143 | 0.87 | CYP1A2 (0.50) | ESR1ACHETSHRGAAACP3 | |
| SCHEMBL30507724 | 0.86 | ESR1 (0.56) | ESR1ACHETSHRGAAACP3 | |
| SCHEMBL598722 | 0.83 | GAA (0.57) | ESR1ACHETSHRGAAACP3 | |
| SCHEMBL3073519 | 0.81 | ESR1 (0.52) | ESR1ACHETSHRGAAACP3 | |
| SCHEMBL342736 | 0.81 | ESR1 (0.52) | ESR1ACHETSHRGAAACP3 | |
| SCHEMBL231827 | 0.81 | ESR1 (0.52) | ESR1ACHETSHRGAAACP3 | |
| SCHEMBL17446315 | 0.79 | ESR1 (0.50) | ESR1ACHETSHRGAAACP3 | |
| SCHEMBL14040083 | 0.79 | ESR1 (0.50) | ESR1ACHETSHRGAAACP3 | |
| SCHEMBL17446316 | 0.79 | ESR1 (0.50) | ESR1ACHETSHRGAAACP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0502372-A1 | 4-tert-Alkyl-2-Methylbenzaldehydedialkylacetals | BASF Aktiengesellschaft (DE) | 1992-09-09 | — | — | EP | claimed |
| CN-118995087-A | Adhesive film and dicing film-die bonding film | 株式会社力森诺科 | 2024-11-22 | — | — | CN | disclosed |
| CN-118053799-A | Method for manufacturing semiconductor device | 株式会社力森诺科 | 2024-05-17 | — | — | CN | disclosed |
| CN-117157733-A | Method for manufacturing semiconductor device and dicing die-bonding integrated film | 株式会社力森诺科 | 2023-12-01 | — | — | CN | disclosed |
| CN-110945634-B | Heat-dissipating die bonding film and dicing die bonding film | 株式会社力森诺科 | 2023-08-29 | — | — | CN | disclosed |
| CN-112292431-B | Crystal cutting and crystal bonding integrated film and pressure-sensitive adhesive film used by same | 昭和电工材料株式会社 | 2022-09-02 | — | — | CN | disclosed |
| US-10577346-B2 | Benzobicycloalkane derivatives, their preparation and pharmaceutical use thereof | SHANGHAI HAIYAN PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) | 2020-03-03 | — | — | US | disclosed |
| WO-2019135136-A1 | COORDINATION COMPLEXES HAVING MICROBIAL ACTIVITY AND INCORPORABLE IN HYALURONIC ACID COMPOSITIONS | LAB SRL (IT) | 2019-07-11 | — | — | WO | disclosed |
| US-20190161468-A1 | BENZODICYCLOALKANE DERIVATIVE, PREPARATION METHOD AND USE THEREOF | SHANGHAI HAIYAN PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) | 2019-05-30 | — | — | US | disclosed |
| CN-108238996-A | The synthetic method of drug synthesis intermediate P―Carboxybenzenesulfonamide | 成都切斯特科技有限公司 | 2018-07-03 | — | — | CN | disclosed |
| US-20100196319-A1 | 4, 5-RING ANNULATED INDOLE DERIVATIVES FOR TREATING OR PREVENTING OF HCV AND RELATED VIRAL INFECTIONS | SCHERING CORPORATION (US) | 2010-08-05 | — | — | US | disclosed |
| EP-1553450-B1 | Process for preparing plugged-through-hole printed wiring board and plugged-through-hole printed wiring board | SAN EI KAGAKU CO (JP) | 2010-05-26 | — | — | EP | disclosed |
| US-20080070303-A1 | Using myocardial and/or muscle progenitor cells as modeling tool in tissue engineering; regenerative medicine and organ replacement | ADVANCED CELL TECHNOLOGY | 2008-03-20 | — | — | US | disclosed |
| EP-1472293-A4 | SOLID CATALYST COMPONENT FOR POLYMERIZATION OF OLEFINS, CATALYST COMPRISING THE SAME AND USE THEREOF | CHINA PETROLEUM & CHEMICAL (CN) | 2008-01-16 | — | — | EP | disclosed |
| WO-2005041904-A2 | INHIBITORS OF CORONAVIRUS PROTEASE AND METHODS OF USE THEREOF | FULCRUM PHARMACEUTICALS, INC. (US) | 2005-05-12 | — | — | WO | disclosed |
| EP-1472293-A1 | SOLID CATALYST COMPONENT FOR POLYMERIZATION OF OLEFINS, CATALYST COMPRISING THE SAME AND USE THEREOF | China Petroleum & Chemical Corporation (CN) | 2004-11-03 | — | — | EP | disclosed |
| WO-2003068828-A1 | SOLID CATALYST COMPONENT FOR POLYMERIZATION OF OLEFINS, CATALYST COMPRISING THE SAME AND USE THEREOF | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2003-08-21 | — | — | WO | disclosed |
| JP-2000095777-A | PRODUCTION OF ALPHA, ALPHA'-DISUBSTITUTED XYLENE | SHOWA DENKO KK | 2000-04-04 | — | — | JP | disclosed |
| US-5236934-A | Angiotensin inhibitors | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-08-17 | — | — | US | disclosed |
| EP-0311387-A2 | Aromatic amine resins, their production process and thermosetting resin compositions making use of the same | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1989-04-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100196319-A1 | 4, 5-RING ANNULATED INDOLE DERIVATIVES FOR TREATING OR PREVENTING OF HCV AND RELATED VIRAL INFECTIONS | ZC3HAV1, IDO1, ZC3HAV1L | ESR1 2725/4885ACHE 1763/4885TSHR 1385/4885 |
| US-20190161468-A1 | BENZODICYCLOALKANE DERIVATIVE, PREPARATION METHOD AND USE THEREOF | CYP3A7, CYP2A7, CYP2J2 | ESR1 2384/4885ACHE 713/4885TSHR 4624/4885 |
| US-10577346-B2 | Benzobicycloalkane derivatives, their preparation and pharmaceutical use thereof | CYP3A7, UGT2B7, BDKRB1 | ESR1 2766/4885ACHE 300/4885TSHR 4533/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.